Global Non-alcoholic Steatohepatitis Supplements Market - 2023-2030

Non-alcoholic Steatohepatitis Supplement [195 Pages] Report on Global Non-Alcoholic Steatohepatitis Supplement Market reached US$ million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,015.59 million by 2030. The market is growing at a CAGR of 3.8% during the forecast period (2023-2030). Non-Alcoholic Steatohepatitis is a type of liver disease in which fat accumulates in the livers of people who do not consume alcohol.

This causes inflammation of the liver and cell damage, which can lead to cirrhosis (liver scarring) and liver failure. People who have nonalcoholic steatohepatitis are more likely to develop liver cancer. Also known as NASH. There are no FDA-approved NASH medications. Probiotics, synbiotics, prebiotics, and postbiotics, as well as certain herbal products like milk thistle and curcumin, are some of the best supplements to help reduce fat buildup in the liver.

Non-alcoholic Steatohepatitis Supplement Market Dynamics

The growing body of scientific research supporting the use of certain supplements in the management of non-alcoholic steatohepatitis (NASH) and related metabolic disorders is expected to drive market growth in the forecast period.

The use of certain supplements in the treatment of non-alcoholic steatohepatitis (NASH) and related metabolic disorders is being supported by a growing body of scientific research. The potential advantages of NASH supplements have become more widely known among patients and medical professionals thanks to this study. For instance, clinical studies have shown that omega-3 fatty acids, such as those found in fish oil, may help to improve liver function, reduce inflammation, and improve lipid profiles in patients with NASH. Vitamin E has also been shown to have antioxidant properties that can help to protect liver cells from damage, and probiotics may help to improve gut health and reduce inflammation, which is often a contributing factor to NASH.

As healthcare professionals become more familiar with the research on NASH supplements, they are increasingly recommending them as part of a comprehensive treatment plan for patients with NASH and related conditions. Patients are also becoming more aware of the potential benefits of these supplements and are seeking them out as part of their self-care routine. Overall, increasing awareness among healthcare professionals and patients about the potential benefits of NASH supplements is driving their use in the management of NASH and related metabolic disorders. However, it is important to note that supplements should be used in conjunction with lifestyle changes and under the guidance of a healthcare professional to ensure safe and effective use.

The NASH supplement market is still emerging, and many consumers may be unaware of the potential benefits of using supplements for NASH management is expected to be a barrier to market growth during the forecast period.

Non-alcoholic steatohepatitis (NASH) supplements, like any other supplement or medication, may have unwanted side effects or interact with other medications. For example, high doses of vitamin E supplements may increase the risk of bleeding in patients who are taking blood-thinning medications, and omega-3 fatty acid supplements may interact with certain cholesterol-lowering medications.

Additionally, the safety and efficacy of supplements may vary depending on the individual patient's medical history and other medications they may be taking. For example, some supplements may not be safe for patients with liver or kidney disease, and others may interact with medications used to treat diabetes. Therefore, it is important for patients and healthcare providers to carefully evaluate the potential risks and benefits of using NASH supplements, and to consider any potential interactions with other medications that the patient may be taking. Patients should also be aware of any potential side effects and report them to their healthcare provider immediately if they occur.

Non-alcoholic Steatohepatitis Supplement Market Segmentation Analysis

The global non-alcoholic steatohepatitis supplement market is segmented based on supplement type, supplement form, nutrition, distribution channel and region.

Owing to their increased insulin sensitivity, decreased glucose and LDL cholesterol absorption, alteration of gut dysbiosis, and induction of short-chain fatty acid synthesis are the factors to drive the market in the forecast period.

Probiotics are naturally occurring, live, beneficial bacteria and/or yeasts that are found in the body. Bacteria are typically viewed negatively as something that sickens people. Yet, both beneficial and dangerous bacteria are present in the body at all times. The beneficial bacteria included in probiotics help to keep the body healthy and functional and also extend to liver function in cirrhosis, nonalcoholic fatty liver disease, and alcoholic liver disease. Probiotics can be found naturally in foods like kimchi and fermented yogurt.

Moreover, they can be found in your gut, where they contribute to a variety of crucial biological processes like vitamin production, mood control, digestion, immune function, digestion, immunological system, and mood regulation. Additionally, probiotics are offered as supplements. High doses of either a single probiotic strain or several probiotic strains are present in these supplements. There are some health advantages associated with probiotic supplementation. Probiotic therapy has been recommended as a treatment for hypertransaminasemia in obese children who are resistant to lifestyle treatments, even though it did not affect adiposity and fatty liver. On the other side, animal and human research have shown that probiotics help strengthen the gut wall, lowering its permeability, bacterial translocation, and endothelia. Also, they have the potential to lessen liver oxidative and inflammatory damage while, in certain cases, enhancing the histology condition.

Furthermore, several probiotic strains have particular abilities to improve liver function through the modulation of the gastrointestinal tract. These improvements were mostly observed with Bifidobacterium, Lactobacillus, and Streptococcus or multispecies probiotic therapy.

One of the key factors boosting the growth of the probiotics market in the United States is the increased interest of middle-aged adults in preserving digestive health. Yogurts and other naturally beneficial sour milk beverages like Kefir and Kombucha, which contain probiotics, have seen rapid expansion in the nation. These products may help prevent liver-related illnesses and other infections. According to American Liver Foundation October 2022, the most prevalent chronic liver disease in the US is NAFLD. In the United States, roughly 25% of adults are thought to have NAFLD. About 20% of people with NAFLD also have NASH (5% of American adults). Most NAFLD patients just have fatty livers. It is unclear why some NAFLD patients develop basic fatty liver and others develop NASH, though some genes may be involved, according to studies. The other driver of the segment's expansion is the growth in diseases. For instance, according to International Probiotics Association, September 2021, probiotics are a top-selling supplement category on Amazon.com. Sales of probiotic supplements increased by 48% in 2020 compared to the previous year, dominating the category on Amazon.com, where NASH probiotic supplements are included. Sales growth indicates that the segment is expanding.

Global Non-alcoholic Steatohepatitis Supplement Market Geographical Share

The increasing prevalence of obesity, raising NASH incidence, and expansion of manufacturing units by the market players have driven the region’s growth in the forecast period.

Asia-Pacific region accounted for the largest market share in 2022. Owing to the increasing prevalence of obesity, raising NASH incidence, and increasing product launches are the factors to drive the region's growth in the forecast period. For instance, In many Asian nations, including South Korea, the obesity epidemic is on the rise, and this is also true with NAFLD. The prevalence of obesity in South Korea increased from 34.1% in 2017 to 38.3% in 2020, according to data from the Korea National Health and Nutrition Examination Survey (KNHANES), coinciding with changes in lifestyles that include high-calorie diets, a sedentary lifestyle, and excessive stress. Compared to the general population, people with obesity or diabetes mellitus have a higher frequency of NAFLD. Compared to Koreans who eat more vegetables, fish, and soy products, those who consume diets high in noodles, dumplings, and red meat have a much-increased chance of developing NAFLD. Over 45,000 persons between the ages of 40 and 69 are affected by liver disease in the Korean region. Individuals with NASH may develop liver fibrosis, and hepatic fibrosis can advance to cirrhosis, putting them at high risk of mortality from liver failure or liver cancer. Therefore, it has increased the demand for non-alcoholic steatohepatitis supplements in the region. Thus, from the above factors, the Asia-Pacific region accounted for the largest market share in the forecast period.

Non-alcoholic Steatohepatitis Supplement Companies

The major global players include Nature's Bounty (Nestlé), NOW Foods, Herbalife International of America, Inc., DANONE S.A., ADM, Irwin Naturals, Oregon's Wild Harvest, Jarrow Formulas, Inc, Gaia Herbs and Nutra-Life Australia.

Key Developments
• In June 8, 2021, Gaia Herbs announced the extension of its award-winning Turmeric Supreme line with two new delicious and convenient USDA Certified Organic and Non-GMO Project Verified gummy supplements: Turmeric Supreme Adult Daily Gummies and Turmeric Supreme Extra Strength Gummies. Both varieties are now available on GaiaHerbs.com and began rolling out nationally at natural and health food stores at the beginning of June.
• In March 16, 2021, Gaia Herbs announced the release of six mushroom capsule supplements that help to support whole-body health and wellness: Respiratory Mushroom Blend, Immune Mushroom Blend, Reishi Mushroom, Lion's Mane Mushroom, Cordyceps Mushroom, and Turkey Tail Mushroom. These products are intended to support lung, immune, heart, brain, and neurological health; provide energy and stamina support; stress support; and support for healthy liver function, in that order. All six varieties are now available on GaiaHerbs.com and will be available in natural and health food stores nationwide beginning in March.
• In September 2021, Vibrant Nutraceuticals which is a part of The GHT Companies rolled out Plumisol a tablet supplement that promotes liver health, the main ingredient present in it is prunus mume an extract from the exotic tree, due to its liver-protecting, antioxidant, and anti-inflammatory properties.

The global non-alcoholic steatohepatitis supplement market report would provide approximately 69 tables, 70 figures, and 195 Pages.